We now offer Private Weight Loss Treatments

Melanotan II: tanning sprays, injections, safety and UK rules

Paper shield, reference cards and pencil illustrating questions about safety and supporting evidence.
PEPTIDES · 11 minute read
Rahul Puri
Written by Rahul PuriPharmacist, MPharm
Medically reviewed 3 November 2026
Share:
Stay informed

Get practical health advice and updates on Puri Pharmacy services straight to your inbox.

Melanotan II is an experimental peptide promoted for tanning, including in injections and nasal sprays. A change in skin colour is not proof of safety, and it is not a substitute for sun protection. It is not a licensed UK tanning medicine. The regulatory position differs between injections and some nasal products, but being outside medicines regulation does not mean a spray is approved or safe.

At a glance

  • Melanotan II tanning products are not equivalent to an authorised prescription medicine.
  • A needle-free route does not establish safety.
  • Changes in a mole need assessment; do not assume they are an expected tanning effect.
  • Case reports raise concerns but cannot measure an individual’s cancer risk.
  • NHS inform advises stopping Melanotan II and other nasal or injected tanning products.

Puri Pharmacy’s position: we do not sell, supply or prescribe Melanotan II or the experimental tanning products discussed here. Melanotan II remains investigational as a medicine; its online tanning use is not a licensed treatment. We recognise that people may already have used these products and want them to seek advice without judgement. This article explains the evidence and the routes to help, not a dosing or administration protocol.

What is Melanotan II?

Melanotan II, sometimes shortened to MT-II or MT2, is a synthetic melanocortin peptide. It is related to signalling involved in skin pigmentation. Melanin is pigment that contributes to skin colour; changing pigment production is a biological effect, rather than applying colour to the surface in the way a conventional cosmetic self-tanner does.

A 1996 pilot phase-I study reported tanning activity after administration of Melanotan II. That helps explain the interest in the compound, but an early experiment does not validate today’s online preparations, establish long-term safety or show protection from skin cancer.

“Melanotan” is also used loosely in marketing. Similar names can conceal different substances and formulations. Knowing the label is useful when seeking help, but it is not the same as confirming the contents.

Melanotan I, Melanotan II and afamelanotide are not interchangeable

There is a legitimate medicinal context that can make online claims confusing. Afamelanotide is the active substance in Scenesse, an authorised specialist medicine used for erythropoietic protoporphyria, or EPP—a rare condition involving painful sensitivity to light. The EMA explains its specific formulation and medical purpose; the UK Government also identifies Scenesse as an authorised medicine.

This does not make Melanotan II a licensed tanning medicine. It also does not turn a product labelled “Melanotan I” into an authorised Scenesse preparation. Authorisation belongs to a defined medicine with specific conditions of use, not to every product sharing a related name or mechanism.

Licensing and access are separate questions. Specialist treatment for EPP is not a consumer tanning service, and this article is not an offer of that treatment. If a seller borrows the credibility of an authorised medicine, ask whether the exact finished product is actually the same. An association is not equivalence.

Magnifying glass over folded paper loops
Biological activity and a worthwhile health benefit are different outcomes.

Do tanning sprays or injections work?

“Work” needs a defined meaning. A product might change pigmentation without being a safe or appropriate way to do so. A photograph of darker skin cannot show what the product contains, what other exposures occurred, or whether harm will emerge later.

For a nasal preparation, evidence would need to address that route and formulation. Research involving an injection cannot simply establish how much of an unknown spray is absorbed or its effects. Avoiding a needle removes that particular method of administration; it does not remove pharmacological effects or product-quality uncertainty.

It is also misleading to describe a visible tanning effect as sun protection. Continue normal sun-safety measures. The NHS recommends shade, suitable clothing and sunscreen with at least SPF 30 and appropriate UVA protection. Do not increase UV exposure because your skin looks darker.

What are the risks and side effects?

The FDA’s safety review identifies immune-response concerns and published serious-event reports involving Melanotan II, including melanoma and priapism. These reports are warning signals, not proof of causation or a reliable estimate of frequency. The FDA is a US regulator; UK legal questions require UK sources.

The Chartered Trading Standards Institute has warned about nasal tanning sprays, including a reported severe respiratory reaction and the lack of the usual cosmetic safety-assessment framework. A product’s popularity, packaging or influencer endorsement does not answer those concerns.

There is no dependable consumer safety profile covering every online formulation, strength and route. It is therefore inappropriate to offer a precise “safe amount” or a table of reassuring side-effect rates. Lack of an immediate reaction does not establish that continued use is safe.

Does Melanotan II cause melanoma?

The available concern should be explained without exaggeration. A published case report described melanoma in the context of Melanotan II use and sunbed exposure. A case report cannot isolate causation, quantify extra risk or establish what would have happened without those exposures.

It would be wrong to turn that into “Melanotan II definitely caused the cancer”. It would be equally wrong to interpret uncertainty as reassurance. The practical response is to avoid experimental tanning products, avoid harmful UV exposure and arrange assessment of concerning skin changes.

Are Melanotan products illegal in the UK?

The answer requires the exact product and presentation. In a 15 December 2025 parliamentary answer, the Government explained that Melanotan II injections and pens are considered medicinal products. It distinguished nasal products clearly marketed only for self-tanning, without a medical purpose, which fall outside the MHRA’s medicines remit.

That distinction matters. Describing every spray as an illegal medicine would oversimplify the position. Describing a spray outside that remit as “MHRA approved” would also be wrong. Classification is not approval, and other product-safety requirements may still apply.

The Trading Standards warning further explains that nasal tanning products are not covered by the usual UK cosmetics framework. Calling something “cosmetic” in an advert does not establish that it has undergone the assessment expected of an ordinary skin cosmetic.

For products presented as medicines, the Human Medicines Regulations 2012 framework is relevant. Do not infer permission to sell, supply or advertise from the fact that a website accepts payment. This guide does not recommend suppliers or give individual advice on possession, importation or resale.

Who should avoid these products?

The advice is not restricted to a small “high-risk” group. NHS inform advises people using Melanotan II or other nasal or injectable tanning products to stop. Screening out a few medical conditions does not create a safe-use group.

Children and adolescents, people who are pregnant or breastfeeding, and people with significant medical conditions should not be offered an online tanning protocol as a substitute for clinical advice. A history of skin cancer or a changing mole deserves particular attention in a medical discussion. Those statements are not an invented licensed contraindication list; there is no approved Melanotan II tanning leaflet to draw one from.

Paper balance scales beside a clinical reference book
Bring accurate product details to a clinical conversation.

Already used it? Prepare this information

You do not need to know every detail before asking for help. Say clearly when something is uncertain. Useful information includes:

  • The name on the packaging and photographs of the label.
  • Whether it was a spray, injection or another preparation.
  • When it was used, the amount if known, and when any symptoms began.
  • Other medicines, supplements or substances used around the same time.
  • Sunbed use, substantial sun exposure and any new or changing skin marks.

Do not re-use a product to test whether it caused a reaction. Do not add another product to manage a suspected effect without advice. A normal blood test cannot exclude a skin problem, authenticate the product or certify future use as safe.

A changing mole needs a clinical assessment

Arrange a GP appointment for a mole that changes size, shape or colour, or becomes painful, itchy, inflamed, bleeding or crusty. Do not assume the change is harmless because it followed tanning-product use. See the NHS guidance on melanoma symptoms.

When is urgent help needed?

Call 999 for sudden swelling of the tongue or throat, or difficulty breathing, following NHS anaphylaxis advice. Do not send a routine pharmacy enquiry while waiting for these symptoms to pass.

A prolonged erection also needs prompt attention. The NHS advises calling 999 or going to A&E for an erection lasting more than 3–4 hours, or more than one hour if you have sickle cell disease and a painful erection. Seek advice earlier if you are worried; do not treat the threshold as a reason to ignore worsening symptoms.

What are safer alternatives?

If the goal is a temporary tanned appearance, a conventional self-tanning lotion applied to the skin is a different option from a drug delivered into the nose or by injection. Trading Standards recommends safer skin-applied self-tanners. Follow the finished product’s instructions and stop if it causes irritation; “safer” does not mean every cosmetic suits every person.

Self-tan does not replace sunscreen or shade. If the concern is a pigmentation disorder, unusual light sensitivity or a changing lesion, seek assessment of that problem rather than attempting to alter the colour yourself.

What should athletes know?

A tanning goal does not itself establish permission in sport. The WADA List includes a broad S0 category for non-approved pharmacological substances, as well as other categories. Athletes should obtain an official substance-specific answer through their anti-doping organisation; an absent trade name or a cosmetic sales description is not clearance.

Frequently asked questions

Is a nasal spray safer because it avoids injections?

Not enough evidence supports that reassurance. The route changes the assessment; it does not establish the safety of the substance or finished product.

Is Melanotan II the same as Scenesse?

No. Scenesse contains afamelanotide in a defined specialist medicine. Its authorisation does not approve Melanotan II tanning products.

Does darker skin mean I can stay in the sun longer?

Do not use a colour change to justify more UV exposure. Keep normal sun protection and avoid sunbeds.

Should I wait for a mole to return to normal after stopping?

Do not postpone assessment of a concerning change on that assumption. Tell your GP about the product and the skin change.

Can Puri Pharmacy supply a safer tanning peptide?

No. We do not supply experimental tanning peptides or recommend a supplier. Our purpose is education and appropriate signposting.

Key takeaways

  • Tanning activity and safety are separate questions.
  • UK regulation distinguishes some nasal products from injections; neither distinction establishes approval for self-use.
  • Licensed specialist medicines do not validate similarly named online products.
  • A changing mole needs assessment, and severe reactions need urgent care.
  • Avoid experimental tanning products and maintain sun protection.

Evidence summary

This summary draws on the studies and official guidance linked above.

  • What human evidence shows: Early research can show a tanning effect; that is evidence of biological activity.
  • What is not established: It does not establish safe cosmetic use or protection against ultraviolet damage.
  • Main safety uncertainties: Adverse-event reports, changes in pigmentation and uncertain product contents require attention without assuming every reported event proves causation.
  • What would change the assessment: Controlled evidence of meaningful benefit and adequately characterised harms for an identified preparation and use.
Rahul Puri, pharmacist

Ask Rahul

Rahul Puri | Pharmacist

Peptide evidence, safety and UK regulation

Is tanning activity a meaningful benefit?

A visible tan is not a safety outcome. I distinguish evidence that a substance changes pigmentation from evidence that using it improves health. The specialist use of a different licensed medicine does not resolve that question for online melanotan products.

Have a question about a claim? Use our contact form and include the article or study you want explained. Do not post personal health information in public comments. These articles provide education; Puri does not supply the experimental research peptides discussed here.

For symptoms or an individual treatment decision, seek appropriate clinical advice. For urgent symptoms, seek urgent medical care directly rather than waiting for a pharmacy reply.

Share:
Stay informed

Get practical health advice and updates on Puri Pharmacy services straight to your inbox.